Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up study of Gel-One in knee and hip osteoarthritis
jRCT2031240622Active, not recruiting
- Sponsor
- Seikagaku Corporation
- Start
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of sodium hyaluronate in knee osteoarthritis (OA) and hip osteoarthritis, sponsored by Seikagaku Corporation. Started Feb 2025; status: active, not recruiting.
02
Drugs
sodium hyaluronate
03
Conditions
knee osteoarthritis (OA)hip osteoarthritis
Beyond the preview
Go deeper on jRCT2031240622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240622.